1. Home
  2. GXAI vs VRAX Comparison

GXAI vs VRAX Comparison

Compare GXAI & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXAI
  • VRAX
  • Stock Information
  • Founded
  • GXAI 2021
  • VRAX 2013
  • Country
  • GXAI United States
  • VRAX United Kingdom
  • Employees
  • GXAI N/A
  • VRAX N/A
  • Industry
  • GXAI
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GXAI
  • VRAX Health Care
  • Exchange
  • GXAI Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • GXAI 7.5M
  • VRAX 7.3M
  • IPO Year
  • GXAI 2023
  • VRAX 2022
  • Fundamental
  • Price
  • GXAI $1.79
  • VRAX $1.90
  • Analyst Decision
  • GXAI
  • VRAX
  • Analyst Count
  • GXAI 0
  • VRAX 0
  • Target Price
  • GXAI N/A
  • VRAX N/A
  • AVG Volume (30 Days)
  • GXAI 608.1K
  • VRAX 282.7K
  • Earning Date
  • GXAI 03-26-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • GXAI N/A
  • VRAX N/A
  • EPS Growth
  • GXAI N/A
  • VRAX N/A
  • EPS
  • GXAI N/A
  • VRAX N/A
  • Revenue
  • GXAI $2,979.00
  • VRAX $84,872.00
  • Revenue This Year
  • GXAI N/A
  • VRAX $5,169.18
  • Revenue Next Year
  • GXAI N/A
  • VRAX $66.97
  • P/E Ratio
  • GXAI N/A
  • VRAX N/A
  • Revenue Growth
  • GXAI N/A
  • VRAX 7.03
  • 52 Week Low
  • GXAI $1.01
  • VRAX $0.60
  • 52 Week High
  • GXAI $19.20
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • GXAI 49.83
  • VRAX 49.13
  • Support Level
  • GXAI $1.41
  • VRAX $1.58
  • Resistance Level
  • GXAI $1.66
  • VRAX $2.10
  • Average True Range (ATR)
  • GXAI 0.16
  • VRAX 0.25
  • MACD
  • GXAI 0.04
  • VRAX 0.01
  • Stochastic Oscillator
  • GXAI 67.69
  • VRAX 47.88

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: